646 related articles for article (PubMed ID: 17175369)
1. Effect of plasmapheresis for acute humoral rejection after heart transplantation.
Wang SS; Chou NK; Ko WJ; Chi NH; Hung SC; Hsu RB; Yu HY; Chen YS; Chu SH; Tsao CI; Shun CT
Transplant Proc; 2006 Dec; 38(10):3692-4. PubMed ID: 17175369
[TBL] [Abstract][Full Text] [Related]
2. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
3. Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients.
Lones MA; Czer LS; Trento A; Harasty D; Miller JM; Fishbein MC
J Heart Lung Transplant; 1995; 14(1 Pt 1):151-62. PubMed ID: 7727464
[TBL] [Abstract][Full Text] [Related]
4. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.
Thielke JJ; West-Thielke PM; Herren HL; Bareato U; Ommert T; Vidanovic V; Campbell-Lee SA; Tzvetanov IG; Sankary HN; Kaplan B; Benedetti E; Oberholzer J
Transplantation; 2009 Jan; 87(2):268-73. PubMed ID: 19155983
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of acute humoral rejection in a heart transplant patient.
Malafa M; Mancini MC; Myles JL; Gohara A; Dickinson JM; Walsh TE
J Heart Lung Transplant; 1992; 11(3 Pt 1):486-91. PubMed ID: 1610857
[TBL] [Abstract][Full Text] [Related]
6. Reliability and usefulness of immunofluorescence in heart transplantation.
Bonnaud EN; Lewis NP; Masek MA; Billingham ME
J Heart Lung Transplant; 1995; 14(1 Pt 1):163-71. PubMed ID: 7727465
[TBL] [Abstract][Full Text] [Related]
7. Routine surveillance myocardial biopsies are unnecessary beyond one year after heart transplantation.
White JA; Guiraudon C; Pflugfelder PW; Kostuk WJ
J Heart Lung Transplant; 1995; 14(6 Pt 1):1052-6. PubMed ID: 8719450
[TBL] [Abstract][Full Text] [Related]
8. Severe cardiac allograft dysfunction without endomyocardial biopsy signs of cellular rejection: incidence and management.
Veiga Barreiro A; Crespo Leiro M; Doménech García N; Paniagua MJ; Vázquez Martul E; González Cuesta M; Ramírez C; Juffé Stein A; Castro Beiras A
Transplant Proc; 2004 Apr; 36(3):778-9. PubMed ID: 15110660
[TBL] [Abstract][Full Text] [Related]
9. Treatment of humoral rejection after heart transplantation.
Grauhan O; Müller J; v Baeyer H; Volk HD; Fietze E; Cohnert T; Meyer R; Pfitzmann R; Mansfeld H; Siniawski H; Warnecke H; Hetzer R
J Heart Lung Transplant; 1998 Dec; 17(12):1184-94. PubMed ID: 9883759
[TBL] [Abstract][Full Text] [Related]
10. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
Koch A; Daniel V; Dengler TJ; Schnabel PA; Hagl S; Sack FU
J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731
[TBL] [Abstract][Full Text] [Related]
11. Electric myocardial impedance registration in humoral rejection after heart transplantation.
Grauhan O; Müller J; Knosalla C; Cohnert T; Siniawski H; Volk HD; Fietze E; Kupetz W; Hetzer R
J Heart Lung Transplant; 1996 Feb; 15(2):136-43. PubMed ID: 8672516
[TBL] [Abstract][Full Text] [Related]
12. Adult living-donor liver transplantation with ABO-incompatible grafts.
Testa G; Vidanovic V; Chejfec G; Gangemi A; Iqpal R; Porubsky M; Pham T; Benedetti E
Transplantation; 2008 Mar; 85(5):681-6. PubMed ID: 18337660
[TBL] [Abstract][Full Text] [Related]
13. Impact of positive PRA on the results of ABO-incompatible kidney transplantation.
Shimmura H; Tanabe K; Tokumoto T; Ishida H; Ishikawa N; Miyamoto N; Shimizu T; Shirakawa H; Setoguchi K; Toma H
Transplant Proc; 2004 Sep; 36(7):2169-71. PubMed ID: 15518789
[TBL] [Abstract][Full Text] [Related]
14. Treatment of antibody-mediated rejection with high-dose immunoglobulins in ABO-incompatible liver transplant recipient.
Urbani L; Mazzoni A; De Simone P; Catalano G; Coletti L; Montin U; Morelli L; Campani D; Pollina L; Biancofiore G; Bindi L; Scatena F; Filipponi F
Transpl Int; 2007 May; 20(5):467-70. PubMed ID: 17263788
[TBL] [Abstract][Full Text] [Related]
15. Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation.
Ibernón M; Gil-Vernet S; Carrera M; Serón D; Moreso F; Bestard O; Cruzado JM; Grinyó JM
Transplant Proc; 2005 Nov; 37(9):3743-5. PubMed ID: 16386524
[TBL] [Abstract][Full Text] [Related]
16. Activation of intravascular macrophages within myocardial small vessels is a feature of acute vascular rejection in human heart transplants.
Ratliff NB; McMahon JT
J Heart Lung Transplant; 1995; 14(2):338-45. PubMed ID: 7779854
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience of tacrolimus with everolimus in heart transplantation.
Wang SS; Chou NK; Chi NH; Huang SC; Wu IH; Wang CH; Yu HY; Chen YS; Tsao CI; Ko WJ; Shun CT
Transplant Proc; 2012 May; 44(4):907-9. PubMed ID: 22564581
[TBL] [Abstract][Full Text] [Related]
18. How successful is OKT3 rescue therapy for steroid-resistant acute rejection episodes after heart transplantation?
Wagner FM; Reichenspurner H; Uberfuhr P; Kur F; Kaulbach HG; Meiser BM; Ziegler U; Reichart B
J Heart Lung Transplant; 1994; 13(3):438-42; discussion 442-3. PubMed ID: 8061020
[TBL] [Abstract][Full Text] [Related]
19. The changing pattern of humoral rejection in cardiac transplant recipients.
Almuti K; Haythe J; Dwyer E; Itescu S; Burke E; Green P; Marboe C; Mancini D
Transplantation; 2007 Aug; 84(4):498-503. PubMed ID: 17713434
[TBL] [Abstract][Full Text] [Related]
20. HLA-DR incompatibility predicts heart transplant rejection independent of immunosuppressive prophylaxis.
Costanzo-Nordin MR; Fisher SG; O'Sullivan EJ; Johnson M; Heroux A; Kao W; Mullen GM; Radvany R; Robinson J
J Heart Lung Transplant; 1993; 12(5):779-89. PubMed ID: 8241215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
